Analysis of 15 cases from a monocentric cohort of 307 liver abscesses
© 2023 Wiley-VCH GmbH. Published by John Wiley & Sons Ltd..
BACKGROUND: Out of the context of haematological patients, Candida sp. is rarely retrieved from pyogenic liver abscesses (PLA).
OBJECTIVES: Our objective was to assess the risk factors for occurrence, and clinical, microbiological characteristics, management and outcome of Candida pyogenic liver abscesses (C-PLA).
PATIENTS/METHODS: We retrospectively analysed C-PLA cases and compared them to pyogenic liver abscesses exclusively due to bacteria (B-PLA) included in our monocentric database on liver abscesses. Unfavourable course was defined as the occurrence of a primary treatment failure (PTF), recurrence after an initial cure, or death within 3 months after diagnosis.
RESULTS: Between 2010 and 2018, 15 C-PLA and 292 B-PLA were included. All C-PLA had a biliary origin and were polymicrobial. All patients with C-PLA had at least one comorbidity at risk for Candida infection and 7 (53.3%) presented with sepsis requiring an admission in intensive care unit. Median duration of antifungal treatment was 42 days [24-55]. In multivariate analysis, compared with B-PLA, a medical history of malignancy (OR 4.16; 95%CI 1.15-18.72) or liver abscess (OR 7.39; 95%CI 2.10-26.62), and sepsis with severity criteria (OR 3.52; 95%CI 1.07-11.90) were independently associated with the occurrence of C-PLA. In multivariate analysis, C-PLA was associated with a higher risk of recurrence (HR 3.08; 95%CI 1.38-11.22).
CONCLUSION: Candida liver abscesses in non-neutropenic is a rare and severe disease. The high rate of recurrence should lead to discuss a more intensive treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
---|---|
Enthalten in: |
Mycoses - 66(2023), 11 vom: 01. Nov., Seite 984-991 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Canouï, Etienne [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 04.10.2023 Date Revised 04.10.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/myc.13636 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360341837 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360341837 | ||
003 | DE-627 | ||
005 | 20231226082819.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/myc.13636 |2 doi | |
028 | 5 | 2 | |a pubmed24n1201.xml |
035 | |a (DE-627)NLM360341837 | ||
035 | |a (NLM)37534436 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Canouï, Etienne |e verfasserin |4 aut | |
245 | 1 | 0 | |a Analysis of 15 cases from a monocentric cohort of 307 liver abscesses |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.10.2023 | ||
500 | |a Date Revised 04.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Wiley-VCH GmbH. Published by John Wiley & Sons Ltd. | ||
520 | |a BACKGROUND: Out of the context of haematological patients, Candida sp. is rarely retrieved from pyogenic liver abscesses (PLA) | ||
520 | |a OBJECTIVES: Our objective was to assess the risk factors for occurrence, and clinical, microbiological characteristics, management and outcome of Candida pyogenic liver abscesses (C-PLA) | ||
520 | |a PATIENTS/METHODS: We retrospectively analysed C-PLA cases and compared them to pyogenic liver abscesses exclusively due to bacteria (B-PLA) included in our monocentric database on liver abscesses. Unfavourable course was defined as the occurrence of a primary treatment failure (PTF), recurrence after an initial cure, or death within 3 months after diagnosis | ||
520 | |a RESULTS: Between 2010 and 2018, 15 C-PLA and 292 B-PLA were included. All C-PLA had a biliary origin and were polymicrobial. All patients with C-PLA had at least one comorbidity at risk for Candida infection and 7 (53.3%) presented with sepsis requiring an admission in intensive care unit. Median duration of antifungal treatment was 42 days [24-55]. In multivariate analysis, compared with B-PLA, a medical history of malignancy (OR 4.16; 95%CI 1.15-18.72) or liver abscess (OR 7.39; 95%CI 2.10-26.62), and sepsis with severity criteria (OR 3.52; 95%CI 1.07-11.90) were independently associated with the occurrence of C-PLA. In multivariate analysis, C-PLA was associated with a higher risk of recurrence (HR 3.08; 95%CI 1.38-11.22) | ||
520 | |a CONCLUSION: Candida liver abscesses in non-neutropenic is a rare and severe disease. The high rate of recurrence should lead to discuss a more intensive treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Candida liver abscess | |
650 | 4 | |a recurrence | |
650 | 7 | |a Polyesters |2 NLM | |
700 | 1 | |a Rossi, Geoffrey |e verfasserin |4 aut | |
700 | 1 | |a Nguyen, Yann |e verfasserin |4 aut | |
700 | 1 | |a Lafont, Emmanuel |e verfasserin |4 aut | |
700 | 1 | |a Rossi, Benjamin |e verfasserin |4 aut | |
700 | 1 | |a Roux, Olivier |e verfasserin |4 aut | |
700 | 1 | |a Dokmak, Safi |e verfasserin |4 aut | |
700 | 1 | |a Bert, Frédéric |e verfasserin |4 aut | |
700 | 1 | |a Leflon-Guibout, Véronique |e verfasserin |4 aut | |
700 | 1 | |a Fantin, Bruno |e verfasserin |4 aut | |
700 | 1 | |a Lefort, Agnès |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Mycoses |d 1990 |g 66(2023), 11 vom: 01. Nov., Seite 984-991 |w (DE-627)NLM01265194X |x 1439-0507 |7 nnns |
773 | 1 | 8 | |g volume:66 |g year:2023 |g number:11 |g day:01 |g month:11 |g pages:984-991 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/myc.13636 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 66 |j 2023 |e 11 |b 01 |c 11 |h 984-991 |